Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Original Research

Published on 07 Jan 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Aleksandra Antonczyk
Katarzyna Kluzek
Natalia Herbich
Mahdi Eskandarian Boroujeni
Bart Krist
Dorota Wronka
Anna Karlik
Lukasz Przybyl
Adam Plewinski
Joanna Wesoly

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471182

4,788 views
3 citations

Editorial

Published on 07 Jan 2025

Editorial: Chronobiology in cardiometabolic health and disease

in Cardiovascular and Smooth Muscle Pharmacology

Cristina Manuela Dragoi
Zhihong Yang
Baharan Fekry
Andrea Brenna

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544963

1,736 views
3 citations

Editorial

Published on 06 Jan 2025

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Sönke Schildt
Daniel Reichart
Simon Lebek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544594

1,956 views

Editorial

Published on 06 Jan 2025

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

in Cardiovascular and Smooth Muscle Pharmacology

Kaidi Ren
Yang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1543291

1,030 views

Original Research

Published on 03 Jan 2025

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

in Cardiovascular and Smooth Muscle Pharmacology

Min Chen
Yingying Xiao
Jijian Zheng
Peibin Zhao
Lin Cheng
Chuan Jiang
Sixie Zheng
Zheng Wang
Sijuan Sun
Lincai Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449831

2,141 views
1 citation

Original Research

Published on 03 Jan 2025

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

in Cardiovascular and Smooth Muscle Pharmacology

Qian Guo
Xinghua Xu
Xiaohui Li
Yang Mao
Shengqiang Li
Yuxin Yao
Xiang Li
Yaxing Li
Jiayue Feng
Yan Shu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1514293

3,166 views
4 citations

Case Report

Published on 03 Jan 2025

Antithrombotic therapy for a case report of acute myocardial infarction after laparoscopic radical cystectomy

in Cardiovascular and Smooth Muscle Pharmacology

Zilong Wang
Huisheng Yuan
Junhao Chu
Shishuai Duan
Zhihui Zhang
Changze Song
Muwen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477715

2,008 views

Original Research

Published on 20 Dec 2024

Tenecteplase: biochemical and clot lysis activity comparisons

in Cardiovascular and Smooth Muscle Pharmacology

Jan Bechmann
Ira Schmid
Simone Brand
Felix Miller
Chengzhi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498116

6,860 views

Review

Published on 17 Dec 2024

Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management

in Cardiovascular and Smooth Muscle Pharmacology

Victorita Sorodoc
Andreea Asaftei
Alexandr Ceasovschih
Catalina Lionte
Simina Crisan
Mihai Constantin
Lucia Indrei
Laurentiu Sorodoc

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457280

11,312 views
4 citations

Correction

Published on 13 Dec 2024

Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway

in Cardiovascular and Smooth Muscle Pharmacology

Shengnan Li
Jingjing Zhang
Yuewen Zhao
Li Kang
Haipeng Jie
Bo Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532331

1,373 views
1 citation

Original Research

Published on 13 Dec 2024

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction

in Cardiovascular and Smooth Muscle Pharmacology

Chia-Chen Lee
David Te-Wei Kuan
Kai-Chun Chang
Zheng-Wei Chen
Jen-Fang Cheng
Ting-Tse Lin
Lian-Yu Lin
Cho-Kai Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507326

2,269 views
2 citations

Original Research

Published on 12 Dec 2024

Brg1 and RUNX1 synergy in regulating TRPM4 channel in mouse cardiomyocytes

in Cardiovascular and Smooth Muscle Pharmacology

Tao Ban
Xianhui Dong
Ziyue Ma
Jing Jin
Jing Li
Yunfeng Cui
Yuyang Fu
Yongzhen Wang
Yadong Xue
Tingting Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494205

2,850 views
1 citation

Original Research

Published on 06 Dec 2024

Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury

in Cardiovascular and Smooth Muscle Pharmacology

Jing Li
Yiyong Wei
Yi Wang
Yue Zhang
Ying Xu
Huanhuan Ma
Lulin Ma
Qingfan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470142

2,235 views
1 citation

Editorial

Published on 03 Dec 2024

Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease

in Cardiovascular and Smooth Muscle Pharmacology

Adeniyi M. Adebesin
Richard Joseph Roman
William B. Campbell
John M. Seubert
Rheem A. Totah

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531166

1,530 views
1 citation

Original Research

Published on 29 Nov 2024

O304 alleviates abdominal aortic aneurysm formation via AMPK/mTOR/MMP pathway activation

in Cardiovascular and Smooth Muscle Pharmacology

Daohan Sun
Yaming Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457817

2,573 views
3 citations

Original Research

Published on 27 Nov 2024

Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway

in Cardiovascular and Smooth Muscle Pharmacology

Xun Yuan
Li Pan
Chi Zhang
Qiulian Zhu
Zexin Huang
Yuan Qin
Guiping Zhang
Zhimei Feng
Caixian Yang
Ning Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499542

3,111 views
5 citations

Original Research

Published on 26 Nov 2024

Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis

in Cardiovascular and Smooth Muscle Pharmacology

K. Melissa Hallow
Peter J. Greasley
Hiddo J. L. Heerspink
Hongtao Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1332388

2,012 views

Original Research

Published on 25 Nov 2024

Transglutaminase 2 regulates endothelial cell calcification via IL-6-mediated autophagy

in Cardiovascular and Smooth Muscle Pharmacology

Bo Liu
Zhiyuan Cai
Yan Wang
Xinye Liu
Bin Zhang
Qian Zheng
Jingye Li
Cien Li
Yuanbo Cui
Pengju Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393534

2,640 views
2 citations

Original Research

Published on 25 Nov 2024

Diagnostic and prognostic values of HCG15 and morrbid in acute myocardial infarction

in Cardiovascular and Smooth Muscle Pharmacology

Min Huang
Bohua Wu
Xiuxia Ou
Shuo Sun
Kedong Han
Lijian Li
Haiyan Liang
Chunchan Qiu
Qingbo Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1492746

1,360 views
4 citations

Original Research

Published on 21 Nov 2024

Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta

in Cardiovascular and Smooth Muscle Pharmacology

Eric Xavier Dos Santos
José Britto-Júnior
João Victor Ribeiro
Gilberto Quirino Junior
Antonio Tiago Lima
Manoel Odorico Moraes
Maria Elisabete A. Moraes
Edson Antunes
André Schenka
Gilberto De Nucci

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507802

2,372 views

Original Research

Published on 20 Nov 2024

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

in Cardiovascular and Smooth Muscle Pharmacology

Xiao Wang
Xinting Chen
Yuting Wang
Xinyu He
Lan Li
Xiaodan Wang
Yuting Huang
Guanwei Fan
Jingyu Ni

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467132

5,845 views
11 citations

Review

Published on 19 Nov 2024

Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias

in Cardiovascular and Smooth Muscle Pharmacology

Yilin Pan
Yanan Zhao
Hangyu Ren
Xintong Wang
Caixia Liu
Beibei Du
Kumaraswamy Nanthakumar
Ping Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513913

2,439 views
5 citations

Original Research

Published on 18 Nov 2024

Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan

in Cardiovascular and Smooth Muscle Pharmacology

Marco L. Freschi
Axel Künstner
Gianna Huber
Ines Stölting
Hauke Busch
Misa Hirose
Walter Raasch

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453989

2,848 views
1 citation

Review

Published on 18 Nov 2024

Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders

in Cardiovascular and Smooth Muscle Pharmacology

Hang Zhang
Yin-mei Ban
De-mei Li
Gang Wang
Juan Gu
Lei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406510

2,784 views
2 citations

1,408 articles

articles

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Editorial: Chronobiology in cardiometabolic health and disease

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

Antithrombotic therapy for a case report of acute myocardial infarction after laparoscopic radical cystectomy

Tenecteplase: biochemical and clot lysis activity comparisons

Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management

Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction

Brg1 and RUNX1 synergy in regulating TRPM4 channel in mouse cardiomyocytes

Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury

Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease

O304 alleviates abdominal aortic aneurysm formation via AMPK/mTOR/MMP pathway activation

Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway

Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis

Transglutaminase 2 regulates endothelial cell calcification via IL-6-mediated autophagy

Diagnostic and prognostic values of HCG15 and morrbid in acute myocardial infarction

Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias

Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan

Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders